Viewing Study NCT06257693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2025-12-25 @ 11:16 PM
Study NCT ID: NCT06257693
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2023-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Sponsor: Alessa Therapeutics Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-06-21
Start Date Type: ACTUAL
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-08
Completion Date Type: ESTIMATED
First Submit Date: 2023-12-14
First Submit QC Date: None
Study First Post Date: 2024-02-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-26
Last Update Post Date: 2024-06-28
Last Update Post Date Type: ACTUAL